To better elucidate the role of macrophages in bone morphogenetic protein (BMP)-induced bone repair, this study evaluated the effects of macrophages on the migration, metabolic activity and BMP-2-induced osteogenic differentiation of human mesenchymal stem cells (hMSCs). Human monocytes were induced into a macrophage phenotype, and the conditioned media (CM) from undifferentiated monocytes and differentiated macrophages were collected for treatment of hMSCs. Expression levels of osteoblastic marker genes, alkaline phosphatase (ALP) activity and mineral deposition were assessed. The migration of hMSCs was significantly decreased after treatment with the macrophage CM (but not monocyte CM), in a dose-dependent manner. Significant inhibition of hMSC metabolism was observed on days 3 and 7 after treatment with the macrophage CM. The osteoblastic marker genes analyzed (ALP, bone sialoprotein, osteocalcin and runt-related transcription factor-2) after exposure of hMSCs to BMP-2 were all significantly downregulated in cells treated with the macrophage CM. The hMSCs treated with macrophage CM showed significantly decreased enzymatic activity of ALP and calcium content compared with those treated with monocyte CM or basal medium. High levels of interleukin-1β and tumor necrosis factor-α found in macrophage CM may mediate these observed effects on hMSCs. We conclude that macrophage CM suppressed the BMP-2-induced osteogenic differentiation of hMSCs, suggesting that macrophages might contribute to decreased osteogenic effects of BMPs in a clinical setting.

Keywords:
Migration, Osteogenic differentiation, Macrophages, Mesenchymal stem cells
1.
Andrew, J.G., S.M. Andrew, A.J. Freemont, D.R. Marsh (1994) Inflammatory cells in normal human fracture healing. Acta Orthop Scand 65: 462–466.
2.
Bertolini, D.R., G.E. Nedwin, T.S. Bringman, D.D. Smith, G.R. Mundy (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319: 516–518.
3.
Chen, G., D.V. Goeddel (2002) TNF-R1 signaling: a beautiful pathway. Science 296: 1634–1635.
4.
Cheng, P., Z.Q. Gao, Y.H. Liu, Y.X. Xue (2009) Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1. Neurosci Lett 451: 52–56.
5.
Cho, H.H., K.K. Shin, Y.J. Kim, J.S. Song, J.M. Kim, Y.C. Bae, C.D. Kim, J.S. Jung (2010) NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 223: 168–177.
6.
Crowther, M., N.J. Brown, E.T. Bishop, C.E. Lewis (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70: 478–490.
7.
Daigneault, M., J.A. Preston, H.M. Marriott, M.K. Whyte, D.H. Dockrell (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5: e8668.
8.
DiPietro, L.A. (1995) Wound healing: the role of the macrophage and other immune cells. Shock 4: 233–240.
9.
Dominici, M., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, E. Horwitz (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315–317.
10.
Gerstenfeld, L.C., T.J. Cho, T. Kon, T. Aizawa, J. Cruceta, B.D. Graves, T.A. Einhorn (2001) Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 169: 285–294.
11.
Gilbert, L., X. He, P. Farmer, J. Rubin, H. Drissi, A.J. van Wijnen, J.B. Lian, G.S. Stein, M.S. Nanes (2002) Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277: 2695–2701.
12.
Giuliani, N., S. Colla, F. Morandi, M. Lazzaretti, R. Sala, S. Bonomini, M. Grano, S. Colucci, M. Svaldi, V. Rizzoli (2005) Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood 106: 2472–2483.
13.
Gordon, S., P.R. Taylor (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953–964.
14.
Grundnes, O., O. Reikeraas (2000) Effects of macrophage activation on bone healing. J Orthop Sci 5: 243–247.
15.
Hemeda, H., M. Jakob, A.K. Ludwig, B. Giebel, S. Lang, S. Brandau (2010) Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev 19: 693–706.
16.
Hess, K., A. Ushmorov, J. Fiedler, R.E. Brenner, T. Wirth (2009) TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 45: 367–376.
17.
Ishiyama, M., Y. Miyazono, K. Sasamoto, Y. Ohkura, K. Ueno (1997) A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44: 1299–1305.
18.
Jian, H., X. Shen, I. Liu, M. Semenov, X. He, X. Wang (2006) Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20: 666–674.
19.
Jones, E.A., S.E. Kinsey, A. English, R.A. Jones, L. Straszynski, D.M. Meredith, A.F. Markham, A. Jack, P. Emery, D. McGonagle (2002) Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46: 3349–3360.
20.
Kaler, P., L. Augenlicht, L. Klampfer (2009) Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 28: 3892–3902.
21.
Khosla, S., J.J. Westendorf, M.J. Oursler (2008) Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118: 421–428.
22.
Kortesidis, A., A. Zannettino, S. Isenmann, S. Shi, T. Lapidot, S. Gronthos (2005) Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105: 3793–3801.
23.
Lacey, D.C., P.J. Simmons, S.E. Graves, J.A. Hamilton (2009) Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage 17: 735–742.
24.
Lai, J.J., K.P. Lai, K.H. Chuang, P. Chang, I.C. Yu, W.J. Lin, C. Chang (2009) Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest 119: 3739–3751.
25.
Lange, J., A. Sapozhnikova, C. Lu, D. Hu, X. Li, T. Miclau 3rd, R.S. Marcucio (2010) Action of IL-1beta during fracture healing. J Orthop Res 28: 778–784.
26.
Liang, F., V. Seyrantepe, K. Landry, R. Ahmad, A. Ahmad, N.M. Stamatos, A.V. Pshezhetsky (2006) Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments. J Biol Chem 281: 27526–27538.
27.
Longobardi, L., L. O’Rear, S. Aakula, B. Johnstone, K. Shimer, A. Chytil, W.A. Horton, H.L. Moses, A. Spagnoli (2006) Effect of IGF-1 in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21: 626–636.
28.
Lucas, T., A. Waisman, R. Ranjan, J. Roes, T. Krieg, W. Muller, A. Roers, S.A. Eming (2010) Differential roles of macrophages in diverse phases of skin repair. J Immunol 184: 3964–3977.
29.
Maes, C., L. Coenegrachts, I. Stockmans, E. Daci, A. Luttun, A. Petryk, R. Gopalakrishnan, K. Moermans, N. Smets, C.M. Verfaillie, P. Carmeliet, R. Bouillon, G. Carmeliet (2006) Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 116: 1230–1242.
30.
Mosser, D.M., J.P. Edwards (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958–969.
31.
Ng, F., S. Boucher, S. Koh, K.S. Sastry, L. Chase, U. Lakshmipathy, C. Choong, Z. Yang, M.C. Vemuri, M.S. Rao, V. Tanavde (2008) PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112: 295–307.
32.
Pasha, Z., Y. Wang, R. Sheikh, D. Zhang, T. Zhao, M. Ashraf (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77: 134–142.
33.
Pollard, J.W. (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9: 259–270.
34.
Ponte, A.L., E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, J. Domenech (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737–1745.
35.
Santavirta, S., Y.T. Konttinen, D. Nordstrom, A. Makela, T. Sorsa, M. Hukkanen, P. Rokkanen (1992) Immunologic studies of nonunited fractures. Acta Orthop Scand 63: 579–586.
36.
Song, H., K. Kwon, S. Lim, S.M. Kang, Y.G. Ko, Z. Xu, J.H. Chung, B.S. Kim, H. Lee, B. Joung, S. Park, D. Choi, Y. Jang, N.S. Chung, K.J. Yoo, K.C. Hwang (2005) Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells 19: 402–407.
37.
Steinert, A.F., B. Proffen, M. Kunz, C. Hendrich, S.C. Ghivizzani, U. Noth, A. Rethwilm, J. Eulert, C.H. Evans (2009) Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 11: R148.
38.
Tang, Y., X. Wu, W. Lei, L. Pang, C. Wan, Z. Shi, L. Zhao, T.R. Nagy, X. Peng, J. Hu, X. Feng, W. Van Hul, M. Wan, X. Cao (2009) TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15: 757–765.
39.
Tsuchiya, S., Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, K. Tada (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42: 1530–1536.
40.
van Amerongen, M.J., M.C. Harmsen, N. van Rooijen, A.H. Petersen, M.J. van Luyn (2007) Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 170: 818–829.
41.
Wang, L., F. Du, X. Wang (2008) TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133: 693–703.
42.
Wang, Q., H. Zhang, B. Zhao, H. Fei (2009) IL-1beta caused pancreatic beta-cells apoptosis is mediated in part by endoplasmic reticulum stress via the induction of endoplasmic reticulum Ca2+ release through the c-Jun N-terminal kinase pathway. Mol Cell Biochem 324: 183–190.
43.
Weitzmann, M.N., C. Roggia, G. Toraldo, L. Weitzmann, R. Pacifici (2002) Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 110: 1643–1650.
44.
Zhou, F.H., B.K. Foster, X.F. Zhou, A.J. Cowin, C.J. Xian (2006) TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res 21: 1075–1088.
45.
Zuk, P.A., M. Zhu, P. Ashjian, D.A. De Ugarte, J.I. Huang, H. Mizuno, Z.C. Alfonso, J.K. Fraser, P. Benhaim, M.H. Hedrick (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279–4295.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.